全部商品分类.jpg)
用小程序，查商品更便捷
产品介绍
产品介绍
产品信息
商品描述
LHF-535 is an antiviral compound. It has EC50s of <1 μM, <1 μM, <1 μM, and 1-10 μM for Lassa, Machupo, Junin, and VSVg virus, respectively.
分子量
412.52
可溶性
In Vitro: DMSO : 96.67 mg/mL (234.34 mM; Need ultrasonic)H2O : (insoluble)
In vitro(体外研究)
LHF-535 is a small-molecule viral entry inhibitor that targets the arenavirus envelope glycoprotein (GP). LHF-535 exhibits potent antiviral activity against a broad array of hemorrhagic fever arenaviruses. LHF-535 inhibits Lassa GP-pseudotyped lentivirus with an IC50 of 0.1-0.3 nM.
In vivo(体内研究)
LHF-535 (3, 10 or 30 mg/kg; orally; daily; 14 days) protectes mice from a lethal challenge with Tacaribe virus and dramatically reduces viral titers in plasma, spleen, and liver. An increase in survival is also observed when the first dose of LHF-535 (10 mg/kg) is delayed by 1, 2, or 3 days after infection, demonstrating that LHF-535 is efficacious as a post-exposure therapeutic in mice.Animal Model:IFN-α/β and-γ receptor-deficient AG129 miceDosage:3, 10, or 30 mg/kg/dayAdministration:Orally; daily; 14 days Result:Effective as a post-exposure therapeutic.
背景
分子式
C27H28N2O2
CAS号
1450929-77-7
制备和贮存
保存方式
Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.
声明 ：本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。